Belite Bio, Inc Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Belite Bio, Inc (BLTE) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $529.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-31
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|
| 2025-12-31 | $529.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $388.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $265.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | $941.00K 20-F · filed 2025-03-17 |